Definium Therapeutics, Inc. · NASDAQ:DFTX

Barrow Robert sold 19,023 Definium Therapeutics, Inc. shares (Form 4)

Traded Sep 2 to Sep 3, 2026 · Filed Sep 4, 2026

From Sep 2 to Sep 3, 2026, Barrow Robert (Director, Chief Executive Officer) sold 19,023 Definium Therapeutics, Inc. shares at US$37.94 for US$722K under a trading plan, leaving 1,494,640 shares. Filed Sep 4, 2026 (Form 4).

Sold
19,023 shares
Price
US$37.94
Value
US$722K
Holding after
1,494,640 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 2, 2026Common SharesAward40,0001,513,663Direct
Sep 3, 2026Common SharesSale19,023US$37.941,494,640Direct

Source

View original at SEC

Related